Skip to main content
Erschienen in: Journal of Cancer Education 2/2016

17.05.2015

Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It?

verfasst von: Joelle I. Rosser, Betty Njoroge, Megan J. Huchko

Erschienen in: Journal of Cancer Education | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Cervical cancer is a leading cause of cancer-related death amongst women in sub-Saharan Africa, largely due to the lack of early screening and treatment. In addition to poor access to screening services, inadequate uptake of available services is a barrier to early identification of precancerous lesions. Given that cervical cancer is caused by a sexually transmitted virus and is associated with HIV positivity, stigma is one of the potential barriers to the utilization of cervical cancer programs in sub-Saharan Africa. We conducted a cross-sectional survey of 419 women attending health facilities in rural western Kenya to measure levels of cervical cancer and HIV stigma and to measure the associations between cervical cancer stigma, HIV stigma, and HIV status. Women who qualified for cervical cancer screening were asked to complete an oral questionnaire using a modified 9-point HIV stigma scale. Low cervical cancer stigma was reported in this study, with only 85/419 (20.3 %) of respondents answering yes to at least one cervical cancer stigma question. However, cervical cancer stigma was highly correlated with HIV stigma (correlation coefficient 0.72) and was significantly lower in HIV-positive women (p < 0.001). Reducing cervical cancer stigma in the general population is an important part of promoting screening in sub-Saharan Africa.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRefPubMed
3.
Zurück zum Zitat Huchko MJ, Bukusi EA, Cohen CR (2011) Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet 114(2):106–110CrossRefPubMedPubMedCentral Huchko MJ, Bukusi EA, Cohen CR (2011) Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. Int J Gynaecol Obstet 114(2):106–110CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH et al (2009) Implementation of “see-and-treat” cervical cancer prevention services linked to HIV care in Zambia. AIDS 23(6):N1–N5CrossRefPubMedPubMedCentral Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH et al (2009) Implementation of “see-and-treat” cervical cancer prevention services linked to HIV care in Zambia. AIDS 23(6):N1–N5CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L et al (2012) “Worse than HIV” or “not as serious as other diseases”? conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med 74(10):1486–1493CrossRefPubMedPubMedCentral White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L et al (2012) “Worse than HIV” or “not as serious as other diseases”? conceptualization of cervical cancer among newly screened women in Zambia. Soc Sci Med 74(10):1486–1493CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Turan JM, Miller S, Bukusi EA, Sande J, Cohen CR (2008) HIV/AIDS and maternity care in Kenya: how fears of stigma and discrimination affect uptake and provision of labor and delivery services. AIDS Care 20(8):938–945CrossRefPubMed Turan JM, Miller S, Bukusi EA, Sande J, Cohen CR (2008) HIV/AIDS and maternity care in Kenya: how fears of stigma and discrimination affect uptake and provision of labor and delivery services. AIDS Care 20(8):938–945CrossRefPubMed
7.
Zurück zum Zitat Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR (2011) HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav 15(6):1111–1120CrossRefPubMedPubMedCentral Turan JM, Bukusi EA, Onono M, Holzemer WL, Miller S, Cohen CR (2011) HIV/AIDS stigma and refusal of HIV testing among pregnant women in rural Kenya: results from the MAMAS Study. AIDS Behav 15(6):1111–1120CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gatune JW, Nyamongo IK (2005) An ethnographic study of cervical cancer among women in rural Kenya: is there a folk causal model? Int J Gynecol Cancer 15(6):1049–1059CrossRefPubMed Gatune JW, Nyamongo IK (2005) An ethnographic study of cervical cancer among women in rural Kenya: is there a folk causal model? Int J Gynecol Cancer 15(6):1049–1059CrossRefPubMed
9.
Zurück zum Zitat Wood K, Jewkes R, Abrahams N (1997) Cleaning the womb: constructions of cervical screening and womb cancer among rural black women in South Africa. Soc Sci Med 45(2):283–294CrossRefPubMed Wood K, Jewkes R, Abrahams N (1997) Cleaning the womb: constructions of cervical screening and womb cancer among rural black women in South Africa. Soc Sci Med 45(2):283–294CrossRefPubMed
10.
Zurück zum Zitat Weiser SD, Heisler M, Leiter K, Percy-de Korte F, Tlou S, DeMonner S et al (2006) Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med 3(7):e261CrossRefPubMedPubMedCentral Weiser SD, Heisler M, Leiter K, Percy-de Korte F, Tlou S, DeMonner S et al (2006) Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med 3(7):e261CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Rosser JI, Njoroge B, Huchko MJ. Cervical cancer screening knowledge and behavior among women attending an urgan HIV clinic in western Kenya. J Canc Educ. 2015 Rosser JI, Njoroge B, Huchko MJ. Cervical cancer screening knowledge and behavior among women attending an urgan HIV clinic in western Kenya. J Canc Educ. 2015
Metadaten
Titel
Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It?
verfasst von
Joelle I. Rosser
Betty Njoroge
Megan J. Huchko
Publikationsdatum
17.05.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2016
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0843-y

Weitere Artikel der Ausgabe 2/2016

Journal of Cancer Education 2/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.